GlaxoSmithKline secures FDA approval for its pandemic vaccine
GSK to ship H1N1 vaccine in December
On The Web
Site Search
Get the latest news alerts: Follow LTW at Twitter.
Local Tech Wire
RESEARCH TRIANGLE PARK, N.C. – GlaxoSmithKline (NYSE: GSK) plans to begin deliveries of more than 7 million doses of a version of its H1N1 pandemic vaccine to the U.S. in December now that it has received approval from the U.S. Food and Drug Administration.
However, clinical testing continues for the adjuvanted, or boosted, version of the vaccine.
GSK said Tuesday that the FDA had approved its “supplemental biologics application,” clearing the way for production at its vaccine plant in Canada.
The U.S. government has already contracted with GSK for 7.6 million doses.
The unadjuvanted vaccine is for use in adults.
Testing of the adjuvanted – which is boosted by compounds designed to increase the response of the human immune system – is continuing in North America, Europe and Japan, GSK said.
Also on Tuesday, GSK said it had reached an agreement with the World Health Organization to donate 50 million does of the adjuvanted vaccine to developing countries. Shipments should begin before the end of the month, GSK said.
“GSK is committed to supporting governments and health authorities around the world in their efforts to protect their populations against this pandemic. Our commitment recognises the needs of developing countries, and this donation of 50 million doses will enable vaccination to begin soon in some of the world’s poorest countries.” said Andrew Witty, GlaxoSmithKline’s chief executive officer, in a statement.
WHO hailed the agreement.
"We welcome this very generous donation by GlaxoSmithKline, which will go to protect the health of the world's poorest people,” said WHO Director-General Margaret Chan. “This is a real gesture of global solidarity towards those who would not be otherwise able to have access to the vaccine.”
GSK maintains its U.S. headquarters in RTP and employs some 4,000 people in the area.
Copyright 2010 Local Tech Wire. All rights reserved.
Featured
Hot Off The Wire
- Hot Off the Wire – Net naming agency reconsiders ‘xxx’ domain; Huge botnet taken down; Google to digitize historic books in Rome, Florence
- Hot Off the Wire – MySpace plans makeover after exec shakeup; Early PC designer wins Turning technology award; Cisco competitor share’s jump
- Hot Off the Wire – GSK pays $40M to close deal with Maryland firm; Sprint plans to cut debt; Google backs easing of software exports
Venture & Innovation
- Venture briefs – 10th birthday for ‘dot-com bubble’ peak; ‘Startup Bus’ teams entrepreneurs for ideas; Carried interest debate is back; Weebly adds theme site creation tool
- Duke team wins regional Association for Corporate Growth event
- How much is a startup worth? Valuation exchange launches for VC-backed firms
E-mail Preferences
The Skinny
- ‘Social media is a beast’ – So how can your business tame it?
- In tough climate, GSK dedicates plant to fight elephantiasis
- ‘Who’s Cisco?’ New RTP site exec recalls a humble birth
- Google, N.C.? UNC-CH, Carrboro, Chapel Hill want Google Net
- Tweet this from Epic: Three more hints about Gears 3
- ‘The Daily Me’: You want your news mobile, instantly from several sources
- ‘Gears 3’ rumors grow louder – Epic president dropping hints
- Intel-ligent boost for tech – Intel, VCs launch investment alliance
- More Nortel bad news: British pension regulator files $3B claim
- 3D is a ‘game changer’ – What can it do for your business, your dreams?